参考文献/References:
[1] MARUYAMA R,SUZUKI H.Long noncoding RNA involvement in cancer[J].BMB Rep,2012,45(11):604-611.
[2] ZHANG JJ,GUO SH,JIA BQ.Down-regulation of long non-coding RNA MEG3 serves as an unfavorable risk factor for survival of patients with breast cancer[J].Eur Rev Med Pharmacol Sci,2016,20(24):5143-5147.
[3] TERASHIMA M,TANGE S,ISHIMURA A,SUZUKI T.MEG3 long noncoding RNA contributes to the epigenetic regulation of epithelial-mesenchymal transition in lung cancer cell lines[J].J Biol Chem,2017,292(1):82-99.
[4] ZHANG J,YAO T,WANG Y,YU J,LIU Y,LIN Z.Long noncoding RNA MEG3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by regulating miR-21[J].Cancer Biol Ther,2016,17(1):104-113.
[5] SUN L,YANG C,XU J,FENG Y,WANG L,CUI T.Long noncoding RNA EWSAT1 promotes osteosarcoma cell growth and metastasis through suppression of MEG3 expression[J].DNA Cell Biol,2016,35(12):812-818.
[6] TANG W,DONG K,LI K,DONG R,ZHENG S.MEG3,HCN3 and linc01105 influence the proliferation and apoptosis of neuroblastoma cells via the HIF-1α and p53 pathways[J].Sci Rep,2016,6:36268.
[7] HU D,SU C,JIANG M,SHEN Y,SHI A,ZHAO F,et al.Fenofibrate inhibited pancreatic cancer cells proliferation via activation of p53 mediated by upregulation of LncRNA MEG3[J].Biochem Biophys Res Commun,2016,471(2):290-295.
[8] SUN L,LI Y,YANG B.Downregulated long non-coding RNA MEG3 in breast cancer regulates proliferation,migration and invasion by depending on p53’s transcriptional activity[J].Biochem Biophys Res Commun,2016,478(1):323-329.
[9] ZHOU Y,ZHONG Y,WANG Y,ZHANG X,BATISTA DL,GEJMAN R,et al.Activation of p53 by MEG3 non-coding RNA[J].J Biol Chem,2007,282(34):24731-24742.
[10] LU KH,LI W,LIU XH,SUN M,ZHANG ML,WU WQ,et al.Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression[J].BMC Cancer,2013,13(10):461.
[11] SUN M,XIA R,JIN F,XU T,LIU Z,DE W,et al.Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer[J].Tumour Biol,2014,35(2):1065-1073.
[12] 高亚莉,李劲.MEG3抑制视网膜母细胞瘤细胞增殖[J].肿瘤,2016,36(3):294-302.
GAO YL,LI J.MEG3 inhibits the proliferation of retinoblastoma cells[J].Tumor,2016,36(3):294-302.
[13] NORK TM,POULSEN GL,MILLECCHIA LL,JANTZ RG,NICKELLS RW.P53 regulates apoptosis in human retinoblastoma[J].Arch Ophthalmol,1997,115(2):213-219.
[14] BRENNAN RC,FEDERICO S,BRADLEY C,ZHANG J,FLORES-OTERO J,WILSON M,et al.Targeting the p53 pathway in retinoblastoma with subconjunctival Nutlin-3a[J].Cancer Res,2011,71(12):4205-4213.
相似文献/References:
[1]刘瑾 朱豫.视网膜母细胞瘤的治疗进展[J].眼科新进展,2013,33(1):000.
[2]常海敏 杨磊 千新来.Calphostin C对人视网膜母细胞瘤细胞增殖的抑制作用[J].眼科新进展,2013,33(9):000.
[3]崔平 南娜 康洁 李军会 申景然.白藜芦醇对人视网膜母细胞瘤细胞侵袭能力的影响及机制研究[J].眼科新进展,2012,32(1):000.
[4]宋念艺 陈绪涛 张娴.B超、CT及MRI检查在视网膜母细胞瘤诊断中的价值[J].眼科新进展,2012,32(10):000.
[5]张千帆 刘瑞敏 穆红梅 郭洋 申飞 刘莹.白藜芦醇对视网膜母细胞瘤Y79细胞增殖的影响及其机制[J].眼科新进展,2012,32(11):000.
[6]兰兰 惠延年 曾光伟.微小RNA与磷酸化胞外信号调节激酶在视网膜母细胞瘤中的表达及其相关性分析[J].眼科新进展,2013,33(6):000.
[7]覃冬菊,唐罗生,游庆华,等.HSP27、增殖细胞核抗原在视网膜母细胞瘤中的表达[J].眼科新进展,2010,30(5):000.
[8]蒋永强 吴晓梅 连金贤.视网膜母细胞瘤术后23 a未复发1例[J].眼科新进展,2009,29(1):000.
[9]陈雪 李海平 张培 曹安民. 小胶质细胞在视网膜母细胞瘤中的活化及分布研究[J].眼科新进展,2014,34(1):029.
[10]孙燕 张煦 王登廷 祝杰 郑吉琦. Livin、PTEN及MMP-9在视网膜母细胞瘤中的表达及相关性研究[J].眼科新进展,2014,34(2):135.